BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sang R, Stratton B, Engel A, Deng W. Liposome technologies towards colorectal cancer therapeutics. Acta Biomater 2021;127:24-40. [PMID: 33812076 DOI: 10.1016/j.actbio.2021.03.055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Biabangard A, Asoodeh A, Jaafari MR, Mashreghi M. Study of FA12 peptide-modified PEGylated liposomal doxorubicin (PLD) as an effective ligand to target Muc1 in mice bearing C26 colon carcinoma: in silico, in vitro, and in vivo study. Expert Opinion on Drug Delivery 2022. [DOI: 10.1080/17425247.2022.2147505] [Reference Citation Analysis]
2 Sang R, Deng F, Engel A, Goldys E, Deng W. Lipid-polymer nanocarrier platform enables X-ray induced photodynamic therapy against human colorectal cancer cells. Biomedicine & Pharmacotherapy 2022;155:113837. [DOI: 10.1016/j.biopha.2022.113837] [Reference Citation Analysis]
3 Krasteva N, Georgieva M. Promising Therapeutic Strategies for Colorectal Cancer Treatment Based on Nanomaterials. Pharmaceutics 2022;14:1213. [PMID: 35745786 DOI: 10.3390/pharmaceutics14061213] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Yang C, Lin ZI, Chen JA, Xu Z, Gu J, Law WC, Yang JHC, Chen CK. Organic/Inorganic Self-Assembled Hybrid Nano-Architectures for Cancer Therapy Applications. Macromol Biosci 2021;:e2100349. [PMID: 34735739 DOI: 10.1002/mabi.202100349] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Yi X, Shen M, Liu X, Gu J. Emerging strategies based on nanomaterials for ionizing radiation-optimized drug treatment of cancer. Nanoscale 2021;13:13943-61. [PMID: 34477676 DOI: 10.1039/d1nr03034e] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]